Identification of dominant signaling pathways from proteomics expression data

Journal of Proteomics

Volumn 71, Issue 1, 2008, Pages 89-96

  Zubarev, Roman A ^a   Nielsen, Michael L ^a   Fung, Eva M ^a   Savitski, Mikhail M ^a   Kel Margoulis, Olga ^b   Wingender, Edgar ^b   Kel, Alexander ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b BIOBASE GMBH   (Germany)

Author keywords

Genes; Pathway analysis; Protein identification; Proteins; Tandem mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR; FAS ANTIGEN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RNA ANALYSIS; SIGNAL TRANSDUCTION; STRESS; VALIDATION PROCESS;

ANIMALS; ANTIGENS, CD95; CELL LINE, TUMOR; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MINK; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 44049086689     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2008.01.004     Document Type: Article

References (32)

1. Vlahou A., and Fountoulakis M. Proteomic approaches in the search for disease biomarkers. J Chromatogr B Biomed Sci Appl 814 (2005) 11-19
2. Naylor S., and Cavanaghb J. Status of systems biology - does it have a future?. Drug Discov Today BIOSILICO 2 (2004) 171-174
3. www.pathwaymedicine.ed.ac.uk/news_item_division
4. Hood L. A personal view of molecular technology and how it has changed biology. J Proteome Res 1 (2002) 399-409
5. Schilling C.H., Schuster S., Palsson B.O., and Heinrich R. Metabolic pathway analysis: basic concepts and scientific applications in the post-genomic era. Biotechnol Prog 15 (1999) 296-303
6. Schilling C.H., and Palsson B.O. Assessment of the metabolic capabilities of Haemophilus influenzae Rd through a genome-scale pathway analysis. J Theor Biol 203 (2000) 49-283
7. Ideker T., Thorsson V., Ranish J.A., Christmas R., Buhler J., Eng J.K., et al. Integrated genomic and proteomic analysis of a systematically perturbed metabolic network. Science 292 (2001) 929-934
8. Zielinska E. A little lab tackles a big question. Scientist 21 N7 (2007) 37-42
9. Mann M. Quantitative proteomics?. Nat Biotechnol 17 (1999) 954-955
10. Ong S.E., Foster L.J., and Mann M. Mass spectrometric-based approaches in quantitative proteomics. Method 29 (2003) 124-130
11. Linscheid M.W. Quantitative proteomics. Anal Biochem 381 (2005) 64-66
12. McDonald W.H., and Yates J.R. Shotgun proteomics and biomarker discovery. Dis Markers 18 (2002) 99-105
13. Veenstra T.D. Global and targeted quantitative proteomics for biomarker discovery. J Chromatogr B Biomed Sci Appl 847 (2007) 3-11
14. Krull M., Pistor S., Voss N., Kel A., Reuter I., Kronenberg D., et al. TRANSPATH®: an information resource for storing and visualizing signaling pathways and their pathological aberrations. Nucleic Acids Res 34 (2006) D546-D551
15. Matys V., Kel-Margoulis O., Fricke E., Liebich I., Land S., Barre-Dirrie A., et al. TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 34 (2006) D108-D110
16. Kel A., Voss N., Jauregui R., Kel-Margoulis O., and Wingender E. Beyond microarrays: finding key transcription factors controlling signal transduction pathways. BMC Bioinformatics 7 Suppl 2 (2006) S13
17. Haigler H., Ash J.F., Singer S.J., and Cohen S. Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc Natl Acad Sci: USA 75 (1978) 3317-3321
18. Nielsen M.L., Savitski M.M., and Zubarev R.A. Improving protein identification using complementary fragmentation techniques in Fourier transform mass spectrometry. Mol Cell Proteomics 4 (2005) 835-845
19. Savitski M.M., Nielsen M.L., and Zubarev R.A. ModifiComb: a database-independent proteomics tool for detecting known post-translational modifications, finding novel types of modifications and fingerprinting complex protein mixtures. Mol Cell Proteomics 5 (2006) 935-948
20. Nielsen M.L., Savitski M.M., and Zubarev R.A. Extent of modifications in human proteome samples and its effect on dynamic range of analysis in shotgun proteomics. Mol Cell Proteomics 5 (2006) 2384-2391
21. Kel A., Konovalova T., Valeev T., Cheremushkin E., Kel-Margoulis O., and Wingender E. Composite module analyst: a fitness-based tool for identification of transcription factor binding site combinations. Bioinformatics 22 (2006) 1190-1197
22. Blagoev B., Kratchmarova I., Ong S.E., Nielsen M., Foster L.J., and Mann M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 21 (2003) 315-318
23. Ibarrola N., Kalume D.E., Gronborg M., Iwahori A., and Pandey A. A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture. Anal Chem 75 (2003) 6043-6049
24. Everley P.A., Krijgsveld J., Zetter B.R., and Gygi S.P. Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics 3 (2004) 729-735
25. Kratchmarova I., Blagoev B., Haack-Sorensen M., Kassem M., and Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308 (2005) 1472-1477
26. β and cAMP on EGF-induced DNA synthesis. In Vitro Cell Dev Biol 34A (1998) 74-78
27. Holgate S.T. Epithelial damage and response. Clin Exp Allergy 30 (2000) 37-41
28. Friedman D.B., Wang S.E., Whitwell C.W., Caprioli R.M., and Arteaga C.L. Multivariable difference gel electrophoresis and mass spectrometry: a case study on transforming growth factor-β and ERBB2 signaling. Mol Cell Proteomics 6 (2007) 150-169
29. Chun P.W., Kim J.D., Lee C.W., Shireman R.B., and Cantarini W.F. Up- and down-regulation of insulin receptors. J Biol Chem 259 (1984) 2161-2165
30. Rautajoki K.J., Marttila E.M., Nyman T.A., and Lahesmaa R. Interleukin-4 inhibits Caspase-3 by regulating several proteins in the Fas pathway during initial stages of human T helper 2 cell differentiation. Mol Cell Proteomics 6 (2007) 238-251
31. Ben-David H., Sela M., and Mozes E. Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis. Proc Natl Acad Sci U S A 102 (2005) 2028-2033
32. Massagué J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 1 (2000) 169-178